Related Experiment Video

Updated: May 23, 2026

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
09:39

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries

Published on: December 27, 2016

Macrolides and staphylococcal biofilms

Jorge Parra-Ruiz1, Céline Vidaillac, Michael J Rybak

  • 1Service of Infectious Diseases, Hospital Universitario San Cecilio, Avda Dr. Olóriz 16. 18012, Granada, Spain. jordi@ugr.es

Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia
|April 11, 2012
PubMed

Insights

Medical device infections are hard to treat, often requiring implant removal. Macrolide antibiotics show promise against staphylococcal biofilms, offering new hope for implant-related infections.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Medical device-associated infections pose a significant clinical challenge, often necessitating device removal due to limited treatment options.
  • Bacterial biofilm formation is a key factor in the persistence and poor outcomes of these infections, exhibiting high antimicrobial resistance.

Purpose of the Study:

  • To evaluate the clinical potential of macrolide antibiotics against staphylococcal biofilms, which are implicated in implant-related infections.
  • To consolidate existing in vitro and in vivo evidence regarding the anti-staphylococcal biofilm activity of macrolides.

Main Methods:

  • Review of in vitro and in vivo studies investigating macrolide efficacy against staphylococcal biofilms.
  • Analysis of existing data on macrolide activity against Gram-negative bacilli biofilms for comparative insights.

Main Results:

  • Macrolides have demonstrated established anti-biofilm activity against Pseudomonas aeruginosa and other Gram-negative bacteria.
  • Growing evidence suggests macrolides possess anti-staphylococcal biofilm activity, despite some conflicting reports.

Conclusions:

  • Macrolides show potential as a therapeutic option for staphylococcal biofilm infections associated with medical devices.
  • Further clinical investigation into macrolides could significantly advance the treatment of implant-related infections.

More Related Videos

Standardized In vitro Assays to Visualize and Quantify Interactions between Human Neutrophils and Staphylococcus aureus Biofilms07:28

Standardized In vitro Assays to Visualize and Quantify Interactions between Human Neutrophils and Staphylococcus aureus Biofilms

Published on: June 8, 2022

Targeting Biofilm Associated Staphylococcus aureus Using Resazurin Based Drug-susceptibility Assay10:00

Targeting Biofilm Associated Staphylococcus aureus Using Resazurin Based Drug-susceptibility Assay

Published on: May 5, 2016

Related Concept Videos

Biofilms01:29

Biofilms

Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...